PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts2133
Avg. Estimate0.110.20.70.37
Low Estimate0.030.20.60.09
High Estimate0.180.20.770.91
Year Ago EPS0.290.040.740.7
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts2233
Avg. Estimate59.95M57.3M306.37M194.03M
Low Estimate45.3M42.1M295.2M104.2M
High Estimate74.6M72.5M326.6M307.8M
Year Ago Sales66.49M45.44M244.3M306.37M
Sales Growth (year/est)-9.80%26.10%25.40%-36.70%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.0.090.050.090.13
EPS Actual0.290.040.390.14
Difference0.2-0.010.30.01
Surprise %222.20%-20.00%333.30%7.70%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate0.110.20.70.37
7 Days Ago0.110.20.70.37
30 Days Ago0.110.270.610.41
60 Days Ago0.130.270.610.41
90 Days Ago0.130.270.610.41
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A12
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesPDLIIndustrySectorS&P 500
Current Qtr.-62.10%N/AN/A0.22
Next Qtr.400.00%N/AN/A0.25
Current Year-5.40%N/AN/A0.08
Next Year-47.10%N/AN/A0.12
Next 5 Years (per annum)14.00%N/AN/A0.10
Past 5 Years (per annum)-22.12%N/AN/AN/A